The global inhalation and nasal spray generic drugs market is expected to grow at a significant CAGR during the forecast period (2021-2027). Inhalation and nasal spray generic drugs are those that are sold without advertising under their chemical names and a delivery device is usually included with these items. The active ingredient’s intended action can be local or systemic in nature. Nasal spray drugs are designed to be deposited in the nasal or pharyngeal region, whereas inhalation drugs are intended to be deposited in the respiratory system.
The rising prevalence of asthma and COPD, as well as the low cost of generic medications, are propelling the inhalation and nasal spray generic drugs market. Asthma is the most common chronic condition among children globally, according to World Health Organization (WHO) research published in 2019. Asthma affected around 235 million people across the globe in 2019. Low- and lower-middle-income nations account for more than 80% of asthma-related deaths. The risk factor for developing asthma includes inhaled substances and particles that create allergic reactions or irritate the airways whereas risk factor leading to the cause of COPD includes tobacco smoke or second-hand smoke, exposure to indoor or outdoor air pollution, dusts and fumes, and long-term asthma. Furthermore, as per the study conducted by National Health and Planning Commission in 2019, 30 million people in China suffered from asthma and only 28% of the people with asthma have their condition under control.
To Request a Sample of our Report on Inhalation and Nasal Spray Generic Drugs Market: https://www.omrglobal.com/request-sample/inhalation-and-nasal-spray-generic-drugs-market
The major companies operating in the global inhalation and nasal spray generic drugs market are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships and collaborations, mergers and acquisitions, geographical expansion, new product launches, and product innovation to remain competitive in the marketplace. For instance, in January 2021, Symbicort Turbuhaler, a dual-combination therapy developed by AstraZeneca was approved by National Medical Products Administration (NMPA) in China to achieve asthma control among patients. In May 2020, AstraZeneca and Propeller Health announced the collaboration to add smart features to its Symbicort inhaler to digitize the treatment of asthma and COPD.
Market Coverage
- The market number available for – 2020-2027
- Base year- 2020
- Forecast period- 2021-2027
Segment Covered-
- By Drug Class
- By Application
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Novartis International AG, Cipla Inc., and Teva Pharmaceutical Industries Ltd., among others.
(Get 15% Discount on Buying this Report)
A full Report of Inhalation and Nasal Spray Generic Drugs Market is Available @ https://www.omrglobal.com/industry-reports/inhalation-and-nasal-spray-generic-drugs-market
Global Inhalation and Nasal Spray Generic Drugs Market Report by Segment
By Drug Class
- Corticosteroids
- Bronchodilators
- Antihistamines
- Decongestant Sprays
- Other Drug Classes
By Application
- Asthma
- COPD
- Other (Allergic Rhinitis)
Global Inhalation and Nasal Spray Generic Drugs Market Report by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
